glp-1 drugs for weight loss side effects Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Glucagon-like Receptor-1 agonists for obesity:

GLP-1 medications also carry an FDA black box warning for risk of thyroid C-cell tumors, and should not be used by patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2)

J Pharmacol Exp Ther 306:347354

Patients experiencing cyclic vomiting syndrome often report abdominal pain, inability to tolerate food or liquids, dizziness, fatigue, and metabolic complications associated with prolonged vomiting

2019;42(Suppl 1):S10323

The complaint, filed in the Eastern District of Pennsylvania federal court, alleges that gastroparesis is an incurable condition that affects normal muscle movement in the stomach and causes symptoms such as nausea, vomiting, abdominal pain, abdominal bloating, severe dehydration, and other side effects